Durect Corp financial data

Symbol
DRRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
10240 Bubb Road, Cupertino, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98.7 % -14.1%
Quick Ratio 9.86 % +104%
Return On Equity -141 % +36.4%
Return On Assets -30.7 % +42.5%
Operating Margin -931 % +39.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31M shares +0.02%
Common Stock, Shares, Outstanding 31M shares +2.33%
Entity Public Float 39.7M USD -67%
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.9M shares +17.8%
Weighted Average Number of Shares Outstanding, Diluted 30.9M shares +16.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.03M USD -21.6%
Research and Development Expense 10.4M USD -64.6%
Costs and Expenses 20.9M USD -50.5%
Operating Income (Loss) -18.9M USD +52.3%
Nonoperating Income (Expense) 498K USD -95.9%
Net Income (Loss) Attributable to Parent -8.32M USD +69.9%
Earnings Per Share, Basic -0.27 USD/shares +74.3%
Earnings Per Share, Diluted -0.27 USD/shares +77.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11M USD -61.2%
Accounts Receivable, after Allowance for Credit Loss, Current 453K USD -26.7%
Inventory, Net 106K USD -19.7%
Assets, Current 13.2M USD -62%
Property, Plant and Equipment, Net 41K USD -53.4%
Operating Lease, Right-of-Use Asset 2.14M USD -30.7%
Goodwill 2.73M USD -55.8%
Other Assets, Noncurrent 123K USD 0%
Assets 18.3M USD -59.4%
Accounts Payable, Current 309K USD -82.1%
Accrued Liabilities, Current 4.77M USD -17.9%
Contract with Customer, Liability, Current 178K USD
Liabilities, Current 7.71M USD -71.5%
Operating Lease, Liability, Noncurrent 1.12M USD -42.9%
Other Liabilities, Noncurrent 384K USD -35.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD +92.9%
Retained Earnings (Accumulated Deficit) -597M USD -1.41%
Stockholders' Equity Attributable to Parent 9.13M USD -38.2%
Liabilities and Equity 18.3M USD -59.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.77M USD +27%
Net Cash Provided by (Used in) Financing Activities -1.5M USD -115%
Net Cash Provided by (Used in) Investing Activities -887K USD +82%
Common Stock, Shares Authorized 350M shares +133%
Common Stock, Shares, Issued 31M shares +2.33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.2M USD -60.9%
Deferred Tax Assets, Valuation Allowance 116M USD -5.77%
Deferred Tax Assets, Gross 117M USD -6.14%
Operating Lease, Liability 2.21M USD -46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.31M USD +69.9%
Lessee, Operating Lease, Liability, to be Paid 2.5M USD -49.8%
Property, Plant and Equipment, Gross 14M USD -0.56%
Operating Lease, Liability, Current 1.08M USD -7.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.19M USD -15.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.15M USD -22.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 295K USD -67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 166K USD -88.5%
Deferred Tax Assets, Operating Loss Carryforwards 82.2M USD -1.82%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 12.8M USD -5.89%
Lessee, Operating Lease, Liability, to be Paid, Year Four 227K USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 51K USD +15.9%
Share-based Payment Arrangement, Expense 1.92M USD -22.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%